Adam Koopersmith

Adam Koopersmith


Pritzker Group Venture Capital

Adam joined Pritzker Group Venture Capital in 2004 and leads the firm’s healthcare practice. Adam also invests in companies providing innovative SaaS applications and marketplace-driven solutions. Prior to joining Pritzker Group, Adam held various senior operating and business development roles at Sportvision (the world’s leader in technology-based enhancements for live sports programming and a Pritzker Group portfolio company) helping the company grow from the “business plan” stage to eight figures in annual revenue. Prior to Sportvision, Adam worked at Berkshire Partners, a leading private equity investment firm, and as an investment banker at Alex Brown & Sons. Adam currently serves on the boards of Analyte Health, Apervita, G2 Crowd, InterOptic, Kollective, and SilverVue and works closely with AiCure, LevelEx, Outcome Health, PreparedHealth, and SpotHero. Adam graduated with a BS from the Wharton School and an MBA from Northwestern’s Kellogg School of Management.

Learn more about the 2018 Health:Further speakers and get your ticket to hear them speak!